Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

m6A-immune-related lncRNA prognostic signature for predicting immune landscape and prognosis of bladder cancer
Zihao Feng, Yanping Liang, Junjie Cen, et al.
Journal of Translational Medicine (2022) Vol. 20, Iss. 1
Open Access | Times Cited: 51

Showing 1-25 of 51 citing articles:

Liquid biopsy in cancer current: status, challenges and future prospects
Liwei Ma, Huiling Guo, Yunxiang Zhao, et al.
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 28
Exploring m6A modifications in gastric cancer: from molecular mechanisms to clinical applications
Penghui Li, Xiangjie Fang, Di Huang
European journal of medical research (2025) Vol. 30, Iss. 1
Open Access | Times Cited: 1
ZBTB7C m6A modification incurred by METTL3 aberration promotes osteosarcoma progression
Xueying An, Wenshu Wu, Lin Yang, et al.
Translational research (2023) Vol. 259, pp. 62-71
Closed Access | Times Cited: 20
RNA N6-methyladenosine modifications in urological cancers: from mechanism to application
Lei Yang, Jianming Ying, Qian Tao, et al.
Nature Reviews Urology (2024) Vol. 21, Iss. 8, pp. 460-476
Closed Access | Times Cited: 7
Establishment of a prognostic risk prediction model incorporating disulfidptosis-related lncRNA for patients with prostate cancer
Yelisudan Mulati, Cong Lai, Jiawen Luo, et al.
BMC Cancer (2024) Vol. 24, Iss. 1
Open Access | Times Cited: 6
METTL3 and METTL14-mediated N6-methyladenosine modification of SREBF2-AS1 facilitates hepatocellular carcinoma progression and sorafenib resistance through DNA demethylation of SREBF2
Xianjian Wu, Min Zeng, Yunyu Wei, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 4
METTL3/YTHDC1 mediates up-regulation of lncRNA OGRU in an m6A-dependent manner involving in oxidative stress and inflammation of HG-induced Müller cells
ShuHua Fu, Qianqian Zhou, Xin Peng, et al.
Immunology Letters (2025), pp. 106972-106972
Closed Access
Clinical Significance and Pathogenic Mechanisms of Long Non-Coding RNA TRPM2-AS in Cancers
Shichen Huang, Bowen Li, Huanyu Chen, et al.
Technology in Cancer Research & Treatment (2025) Vol. 24
Open Access
Integrated multi-omics analysis reveals key genetic, metabolic, and microbial drivers in bladder cancer insights into molecular subtyping and therapeutic approaches: A tumor marker prognostic study
Zhiyong Tan, Xiaorong Chen, Yinglong Huang, et al.
Research Square (Research Square) (2025)
Closed Access
Identification of biomarkers and mechanism exploration of ferroptosis related genes regulated by m6A in type 2 diabetes mellitus
Jing Wang, Xuying Li, Juan Geng, et al.
Hereditas (2025) Vol. 162, Iss. 1
Open Access
Interactions between long non-coding RNAs and m6 A modification in cancer
Han Zhang, Junjie Wang, Chunyi Liu, et al.
Discover Oncology (2025) Vol. 16, Iss. 1
Open Access
m6A-mediated lncRNA NEAT1 plays an oncogenic role in non-small cell lung cancer by upregulating the HMGA1 expression through binding miR-361-3p
Qi Li, Yue Yin, Mengqi Sun
Genes & Genomics (2023) Vol. 45, Iss. 12, pp. 1537-1547
Closed Access | Times Cited: 9
Characterization and verification of CAF-relevant prognostic gene signature to aid therapy in bladder cancer
Huidong Zhou, Ruqi Li, Jinghong Liu, et al.
Heliyon (2024) Vol. 10, Iss. 3, pp. e23873-e23873
Open Access | Times Cited: 3
TFRC, associated with hypoxia and immune, is a prognostic factor and potential therapeutic target for bladder cancer
Runhua Tang, Haoran Wang, Jianyong Liu, et al.
European journal of medical research (2024) Vol. 29, Iss. 1
Open Access | Times Cited: 3
Effects and mechanisms of N6-methyladenosine RNA methylation in environmental pollutant-induced carcinogenesis
Tong‐Fei Li, Zhijie Xu, Kui Zhang, et al.
Ecotoxicology and Environmental Safety (2024) Vol. 277, pp. 116372-116372
Open Access | Times Cited: 3
Knowledge mapping and current trends of m6A methylation in the field of cancer
Zhu Chunming, Yang Jun, Chengpu Zhang, et al.
Heliyon (2024) Vol. 10, Iss. 4, pp. e26262-e26262
Open Access | Times Cited: 2
Overview of the interplay between m6A methylation modification and non-coding RNA and their impact on tumor cells
正則 兜, Xiao-Ting Ma, Mei-Na Piao, et al.
Translational Cancer Research (2024) Vol. 13, Iss. 6, pp. 3106-3125
Open Access | Times Cited: 2
miRNA/epithelial-mesenchymal axis (EMT) axis as a key player in cancer progression and metastasis: A focus on gastric and bladder cancers
Ameer S. Sahib, Amjid Fawzi, Rahman S. Zabibah, et al.
Cellular Signalling (2023) Vol. 112, pp. 110881-110881
Closed Access | Times Cited: 6
Molecular subgroup establishment and signature creation of lncRNAs associated with acetylation in lung adenocarcinoma
Hao Chen, Yuanyong Wang, Changjian Shao, et al.
Aging (2024) Vol. 16, Iss. 2, pp. 1276-1297
Open Access | Times Cited: 2
Disulfidptosis-related lncRNA signature reveals immune microenvironment and novel molecular subtyping of stomach adenocarcinoma
Jinze Li, Chuqi Xia, Yilin Song, et al.
Heliyon (2024) Vol. 10, Iss. 8, pp. e29005-e29005
Open Access | Times Cited: 2
A pan-cancer analysis of the oncogenic and immunological roles of transglutaminase 1 (TGM1) in human cancer
Ruicheng Wu, Dengxiong Li, Shuxia Zhang, et al.
Journal of Cancer Research and Clinical Oncology (2024) Vol. 150, Iss. 3
Open Access | Times Cited: 2
Unraveling the landscape of m6A RNA methylation in wound healing and scars
Qi Zhang, Liming Dong, Song Gong, et al.
Cell Death Discovery (2024) Vol. 10, Iss. 1
Open Access | Times Cited: 2
Bladder cancer immune-related markers: diagnosis, surveillance, and prognosis
Tiantian Yang, Wanru Luo, Jie Yu, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 2
Bulk and single-cell RNA-sequencing analyses along with abundant machine learning methods identify a novel monocyte signature in SKCM
Yuyao Liu, Haoxue Zhang, Yan Mao, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 6
The prognostic significance and clinical relevance of stem cell characteristic in bladder cancer
Xia Chen, Yuanyuan Yin, Yuming He, et al.
Heliyon (2024) Vol. 10, Iss. 3, pp. e24858-e24858
Open Access | Times Cited: 1
Page 1 - Next Page

Scroll to top